Statens Serum Institute, located in Copenhagen, Denmark, is a prominent institution specializing in vaccine development and public health. The institute focuses on creating vaccines for infectious diseases such as tuberculosis, malaria, and influenza, while also advancing research in adjuvants and immunization strategies. In addition to vaccine production, it plays a crucial role in diagnostics and epidemiological studies, contributing significantly to global health initiatives and the understanding of M. tuberculosis and other pathogens.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

55 Patents

#8 in Copenhagen

#60 in Denmark

#12,932 in the World

Copenhagen, Denmark

Statens Serum Institute

Forward Citations = 425

92 inventors:

Peter Andersen (28 out of 30 patents)

Ida Rosenkrands (11 out of 11 patents)

Claus Aagaard (10 out of 10 patents)

4. Anja Olsen (6 out of 6 patents)

5. Inga Laursen (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Statens Serum Institute. Retrieved from https://idiyas.com/company/statens-serum-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

26 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]